KUALA LUMPUR, Oct 21 (Bernama) -- MoneyHero Limited, a personal finance aggregation and comparison platform, has successfully concluded the Seedly x SingSaver Personal Finance Festival (PFF) 2025, which drew more than 3,800 participants at the Marina Bay Sands Expo and Convention Centre in Singapore.
Now in its sixth year, the event combined the strengths of Seedly and SingSaver to deliver an expanded and interactive experience under the theme “Explore Singapore!”, reflecting on the nation’s achievements while encouraging participants to plan confidently for their financial futures.
The festival focused on three core priorities, namely financial resilience, strategic wealth building, and adapting to a changing global economy. Across 16 hours of sessions, over 65 speakers and panellists shared practical strategies on navigating today’s economic challenges and building long-term financial stability.
Acting Minister for Transport and Senior Minister of State for Finance, Jeffrey Siow headlined a fireside chat with MoneyHero Group Chief Executive Officer, Rohith Murthy, where he highlighted the importance of long-term financial discipline, prudent planning and skills investment to prepare for global uncertainties.
Murthy in a statement said the event underscored the strong demand for financial knowledge and collaborative innovation.
He reaffirmed MoneyHero’s commitment to using artificial intelligence (AI) to enhance the digital experience for users, offering personalised insights while supporting financial institution partners with improved conversion and operational efficiency.
Nineteen sponsors and partners took part in the event, providing immersive brand experiences and direct engagement opportunities to help participants deepen their financial literacy and make informed financial decisions.
The festival coincided with MoneyHero’s second anniversary as a Nasdaq-listed company and reinforced its vision of guiding individuals toward financial resilience through innovation, partnership and a growing ecosystem of trusted financial tools.
-- BERNAMA
Tuesday, 21 October 2025
AM BEST JOINS 2025 SHANGHAI INTERNATIONAL REINSURANCE CONFERENCE
KUALA LUMPUR, Oct 21 (Bernama) -- Global credit rating agency, AM Best is joining a panel discussion at the 2025 Shanghai International Reinsurance Conference, taking place for four days ending Oct 24, in Shanghai, China.
AM Best’s Singapore operations managing director and chief executive officer, Rob Curtis, will join a global reinsurance advisory panel in a closed-door meeting with the theme “Consensus and Mechanisms for Contract Performance Management in the Reinsurance Market”.
In a statement, AM Best said Curtis has been with the company since 2022 and has years of experience in Asia’s insurance markets, with key roles held previously with Hong Kong’s Insurance Authority and the International Association of Insurance Supervisors.
The conference, which has become one of the largest annual meetings for reinsurers worldwide, will take place at the Lingang Xinchen International Conference Center in Shanghai's Lingang Special Area, attracting over 1,300 participants from about two dozen countries and regions.
Headquartered in the United States, AM Best does business in more than 100 countries, with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore, and Mexico City.
-- BERNAMA
AM Best’s Singapore operations managing director and chief executive officer, Rob Curtis, will join a global reinsurance advisory panel in a closed-door meeting with the theme “Consensus and Mechanisms for Contract Performance Management in the Reinsurance Market”.
In a statement, AM Best said Curtis has been with the company since 2022 and has years of experience in Asia’s insurance markets, with key roles held previously with Hong Kong’s Insurance Authority and the International Association of Insurance Supervisors.
The conference, which has become one of the largest annual meetings for reinsurers worldwide, will take place at the Lingang Xinchen International Conference Center in Shanghai's Lingang Special Area, attracting over 1,300 participants from about two dozen countries and regions.
Headquartered in the United States, AM Best does business in more than 100 countries, with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore, and Mexico City.
-- BERNAMA
Datavault AI (NASDAQ: DVLT) Partners with Max International AG to Launch Swiss Digital RWA Exchange, Overcoming Barriers to Institutional Tokenization
Landmark Collaboration Harnesses Patented AI, Swiss Regulatory Fortress, and Fiduciary Expertise to Tokenize $1 Trillion1 + Global RWA Market, Anchored in Zurich’s Gold Hub
BEAVERTON, Ore., Oct 21 (Bernama-GLOBE NEWSWIRE) -- via IBN -- Datavault AI Inc. (NASDAQ: DVLT), a pioneer in patented AI-driven blockchain for secure data and asset monetization, today announces a strategic partnership with Max International AG as its licensed partner. This collaboration will deploy and manage a Switzerland-based Swiss Digital RWA Exchange aimed at maximizing the advantages presented by Switzerland’s robust digital regulatory frameworks. Switzerland is the home of SIX Digital Exchange (SDX)—NASDAQ’s longstanding technological ally for digital asset infrastructure, the world’s leading exchange for digital assets.
The partnership targets institutional adoption of Real World Assets (RWAs) by resolving three critical barriers: regulatory uncertainty, technological scalability, and fiduciary trust. It forms the foundation for Datavault AI’s International Elements Exchange—tokenizing commodities like unmined gold and copper—and the International NIL Exchange for name, image, and likeness rights.
Zurich, Switzerland’s financial powerhouse amplifies the platform’s scale: Handling over 70% of global gold refining and trading², it provides an ideal gateway for RWA tokenization. Datavault AI’s global patent portfolio—covering secure data tokenization, digital twins, and automated compliance across U.S., Europe, and Asia—ensures proprietary enforcement within this regulated ecosystem, enabling tamper-proof, scalable trades.
Key competitive edges include:
• AI-Driven Market Efficiency: Datavault AI’s DataValue® and DataScore® systems deliver transparent, algorithmic valuations for illiquid assets, boosting liquidity and reducing opacity risks.
• Regulatory Fortress: Max International AG supplies Swiss domicile and networks for regulated ledger-based securities issuance and exchange.
• Fiduciary Trust via Human Capital: Featuring a team of experienced financial services personnel and licensed “Fit and Proper” experts, ensuring governance meets Swiss private wealth standards for de-risked institutional capital.
This synergy merges Datavault AI’s patents and NYIAX-derived NASDAQ rigor with Max International AG’s Swiss pedigree, which we believe positions the exchange as a leader in high-value asset tokenization. The immediate milestone is the first regulatory-compliant trade on stablecoin platforms, independent of global shifts like the U.S. Genius Act, thanks to Switzerland’s robust DLT framework.
With tokenized assets projected to surpass $1 trillion¹ by 2030, we believe this venture underscores Datavault AI’s global enterprise value through compliant, automated solutions for complex RWA and NIL monetization.
“We are excited to collaborate with Datavault AI on this institutionally targeted initiative,” said Joachim Wegmann, Managing Director of Max International AG. “By integrating patented technology with our Swiss regulatory anchor and fiduciary expertise, we are creating a platform that resolves adoption barriers and sets the standard for sustainable, long-term tokenization of the world’s most significant assets.”
Nathaniel Bradley, CEO of Datavault AI, stated: “We have been approached by large corporations and governments to address growing demand for blockchain-driven solutions to RWA and NIL monetization—making the complex consumable and giving way to a simple tokenized, automated, fail-proof compliant scale. This partnership with Max International AG propels our exchanges into a trusted Swiss hub, unlocking massive global value.”
About Datavault AI Inc.
Datavault AI Inc. (Nasdaq: DVLT) is leading the way in with proprietary solutions in the visualization, valuation, and monetization of assets in the Web 3.0 environment. Leveraging data sciences and acoustic sciences, the cloud-based platform provides comprehensive solutions serving multiple industries, including HPC software licensing for sports & entertainment, events & venues, biotech, education, fintech, real estate, healthcare, energy and more. The Information Data Exchange® (IDE) enables Digital Twins, licensing of name, image, and likeness (NIL) by securely attaching physical real-world objects to immutable metadata or blockchain objects, fostering responsible AI with integrity. The company's solutions ensure privacy and credential protection. They are completely customizable and offer AI and Machine Learning (ML) automation, third-party integration, detailed analytics and data, marketing automation and advertising monitoring. The company is headquartered in Beaverton, Oregon. Learn more about Datavault AI at www.dvlt.ai.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, and other securities laws. Words such as “expect,” “will,” “anticipates,” “continues” and variations of such words and similar future or conditional expressions are intended to identify forward-looking statements. Such forward-looking statements, including statements herein regarding our partnership and exchange initiatives, business opportunities and prospects, strategy, and patent initiatives, as well as the successful implementation of our patented technologies, are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Readers are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various risks and uncertainties including, but not limited to, the following: risks regarding our ability to realize the anticipated benefits of the partnership specified herein; regulatory and other risks surrounding our ability to establish the RWA exchange; our ability to successfully utilize all intellectual property that has been issued and granted Notices of Allowance; risks regarding our ability to utilize the assets we acquire to successfully grow our market share; risks regarding our ability to open up new revenue streams; our current liquidity position and the need to obtain additional financing to support ongoing operations; general market, economic and other conditions; our ability to continue as a going concern; our ability to maintain the listing of our common stock on Nasdaq; our ability to manage costs and execute on our operational and budget plans; our ability to achieve our financial goals; the degree to which our licensees implement our technologies into their products, if at all; the timeline to any such implementation; risks related to technology innovation and intellectual property, and other risks as more fully described in our filings with the U.S. Securities and Exchange Commission. The information in this press release is provided only as of the date of this press release, and we undertake no obligation to update any forward-looking statements contained in this communication based on new information, future events, or otherwise, except as required by law.
1. https://capitalmarketsblog.accenture.com/a-78-trillion-growth-opportunity-for-wealth-managers
2. https://discoveryalert.com.au/news/switzerland-gold-market-role-2025-exports/
Media Contact:
marketing@dvlt.ai
SOURCE: Datavault AI Inc.
DISCLAIMER: BERNAMA MREM are not accountable for any causes of website defacement, misuse, or illegal activities connected to cryptocurrency, blockchain, tokenisation, or bitcoin. This material should not be considered as guidance or an opinion, as it does not constitute financial or investment advice. Use this information at your own risk; we are not liable for any losses or damages caused by the republication of this article.
--BERNAMA
APF CANADA PLANTS FLAG IN INDO-PACIFIC WITH NEW SINGAPORE OFFICE
KUALA LUMPUR, Oct 21 (Bernama) -- The Asia Pacific Foundation of Canada (APF Canada) has officially opened its Asia Regional Office in Singapore, located in the Manulife Tower at 8 Cross Street in the city’s Central Business District.
APF Canada in a statement said the new office establishes a physical presence for the foundation in the Indo-Pacific and reflects its commitment to deepening Canada’s engagement across the wider region.
“This is a moment 40 years in the making. Our new office will be a place where Canadians can tell the story of today’s and tomorrow’s Canada, refresh perceptions, and build meaningful partnerships across the Pacific,” said APF Canada President & Chief Executive Officer, Jeff Nankivell.
Meanwhile, APF Canada Asia Regional Director, Barrett Bingley said: “We are here to be a force multiplier for the entire Canadian ecosystem. This space will enable collaboration with ASEAN and Indo-Pacific partners, driving innovation and opportunity for both sides of the Pacific.”
The establishment of the office is a core component of APF Canada’s Indo-Pacific Initiative, a comprehensive suite of new programmes and activities supported by the Government of Canada through its 2022 Indo-Pacific Strategy.
The office will enable APF Canada to support Canadians, their institutions, and firms in making a greater impression and establishing new partnerships in Asia, providing an accessible, multipurpose venue for collaborative events and high-level networking for stakeholders across business, government, academia, and the media.
For Canadian and Asian partners, the office offers opportunities to host presentations and events in its flexible convening space; participate in business networking events, industry workshops, expert panels, and training sessions hosted by APF Canada; and engage with high-quality research and analysis, among others.
With its head office in Vancouver and offices in Toronto and Singapore, APF Canada continues to advance its mission to strengthen Canada’s strategic, economic, and people-to-people ties with Asia.
-- BERNAMA
Friday, 17 October 2025
BREAK KINGS & SLUMP VICTIMS: CITY, LIVERPOOL SOAR AS EVERTON FLOUNDER POST-INTERNATIONALS
KUALA LUMPUR, Oct 17 (Bernama) -- As the Premier League snaps back into gear, a new Squawka study reveals which clubs hit the ground running and which stumble after international breaks.
“Post-international fixtures are a litmus test for squad depth and coaching preparation. Our ranking validates what fans sense—but with five seasons of data to back it,” said Squawka Head of Content, Tom Dutton in a statement.
Covering data from October 2020 to the present, the findings underline how top sides like Manchester City and Liverpool excel in these restart fixtures, while others, notably Everton and Crystal Palace, consistently falter.
Manchester City have turned post-break consistency into an art form, losing just once in 17 such matches over five seasons.
Not far behind, Liverpool boast the league’s longest active winning run after international duty—four straight wins—and will aim to extend that when Manchester United visit Anfield on Oct 20.
Arsenal, too, are trending upward, with three consecutive post-break victories since a blip at Bournemouth in October 2024. Aston Villa remain quietly impressive, unbeaten in their last 10 restart fixtures since the 2022 World Cup.
On the flip side, Everton are languishing. With just one win in their last 11 post-international matches, they now face the daunting task of a trip to the Etihad. Crystal Palace's nine-match winless streak after breaks marks the league’s worst, highlighting persistent struggles with squad reintegration.
Squawka’s ranking evaluates the 2025/26 Premier League cohort and includes relevant EFL (League One/Championship) results for promoted clubs. Metrics tracked include win/loss records, goals scored/conceded, and points accrued—shedding light on which teams best manage the transition from international to domestic action.
-- BERNAMA
UPDATE: SINTX Strengthens Infection-Prevention Portfolio with Newly Allowed U.S. Patent Covering $30 Billion Antipathogenic Addressable Market
New U.S. Patent reinforces competitive advantage and enables broader licensing and product opportunities across key markets
SALT LAKE CITY, Utah, Oct 17 (Bernama-GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics innovator specializing in biomedical applications of silicon nitride (Si₃N₄), today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a patent application containing method claims covering the Company’s antipathogenic fabric technology.
This development builds upon SINTX’s previously announced patent allowance for its Antipathogenic Fibrous Materials composition patent, expanding the Company’s Intellectual Property (IP) to protect both the material itself and the processes that bring it to market. This dual coverage strengthens the Company’s competitive advantage, enhances licensing and partnership opportunities, and broadens potential applications across medical textiles, filtration media, and other infection-prone surfaces.
These two patent families create a comprehensive IP competitive barrier around SINTX’s surface-level pathogen-inactivation technology, covering applications in wound dressings, surgical drapes and gowns, filtration media, personal protective equipment (PPE), and high-touch clinical surfaces.
“We are excited to announce the allowance of our Method Patent for Antipathogenic Fibrous Materials, marking a significant milestone that strengthens and broadens the protection of our proprietary silicon nitride technology platform.” said Eric K. Olson, Chairman and CEO of SINTX Technologies. “This newly allowed patent complements the recently issued U.S. Patent No. 12,433,356, granted on October 7, 2025, which covers the composition of silicon nitride for antipathogenic fibrous materials. Together, these patents reinforce SINTX’s leadership in infection-resistant material innovation and expand the Company’s IP protection to cover both the composition of its fabrics and methods by which they are produced and applied. We believe this dual-layer IP foundation significantly enhances the licensing and commercialization potential of our platform.”
Lisa Marie, Del Re, Chief Commercial Officer, added, “With method claims, we can now defend and license the manufacturing and application pathways that unlock silicon nitride’s antipathogenic performance in textiles and surfaces. This is crucial as we engage with potential wound-care, filtration, and medical-textile partners.”
Scientific foundation and external validation
“Peer-reviewed work has repeatedly shown rapid inactivation of coronaviruses and broad antimicrobial activity associated with silicon nitride, including recent data reporting up to ~99.97% reduction of infectious SARS-CoV-2 within minutes under lab conditions,” said Dr. Ryan Bock, Chief Technology Officer. “Non-woven fabrics containing optimized Si₃N₄ powder have also provided significant viral reduction, demonstrating again that our silicon nitride platform is suitable for unlocking antipathogenic properties in a wide range of products.”
Note: Laboratory antiviral/antimicrobial results support the materials platform and are distinct from any cleared device indications.
Market context
Infection-prevention remains a large, multi-segment opportunity. SINTX previously characterized the accessible market for its platform as ~$30B across medical textiles, wound management, filtration/PPE, and healthcare infrastructure—an opportunity now underpinned by composition + method coverage.
At the care-delivery level, ~1 in 31 U.S. hospital patients has at least one healthcare-associated infection (HAI) on any given day, with substantial economic burden—reinforcing demand for passive, surface-level solutions that work continuously at the point of contact. (CDC data; cost ranges widely across HAI types.)
SINTX plans to pursue licensing and co-development partnerships with textile, wound care , and filtration/PPE partners. The dual-patent estate allows SINTX to license both materials embodiments and process methods, enabling flexible deal structures including upfronts, milestones, and royalties across multiple points in the supply-chain node.
For more information, visit www.sintx.com.
About SINTX Technologies, Inc.
Located in Salt Lake City, Utah, SINTX Technologies is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. SINTX is a global leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans since 2008. Through innovation and strategic partnerships, SINTX continues to expand its portfolio across multiple markets.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable securities laws. Forward-looking statements are based on current expectations, estimates, and projections and involve risks and uncertainties that could cause actual results to differ materially. Forward-looking statements often include words such as “anticipate,” “believe,” “expect,” “intend,” “may,” “plan,” “should,” “will,” and similar expressions. Examples in this release include, without limitation, statements regarding the anticipated commercial, licensing, and partnership potential of SINTX’s intellectual property (including newly allowed claims), the Company’s plans to pursue licensing, co-development, or other commercialization arrangements, expectations about market opportunities and expansion into new markets, and the Company’s competitive positioning. These statements are subject to risks and uncertainties, including SINTX’s ability to execute its business strategy; protect and enforce its intellectual property; successfully enter into and perform under licensing and partner relationships; obtain necessary regulatory approvals; achieve market acceptance of new technologies; general economic and industry conditions; and other risks described in SINTX’s filings with the U.S. Securities and Exchange Commission, including the “Risk Factors” sections of its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this release. Except as required by law, SINTX undertakes no obligation to update or revise any forward-looking statements.
Contact:
Jack Perkins or Maria Hocut
KCSA Strategic Communications
Sintx@kcsa.com
SINTX Technologies, Inc.
801.839.3502
IR@sintx.com
SOURCE: SiNtx Technologies, Inc.
SALT LAKE CITY, Utah, Oct 17 (Bernama-GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics innovator specializing in biomedical applications of silicon nitride (Si₃N₄), today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a patent application containing method claims covering the Company’s antipathogenic fabric technology.
This development builds upon SINTX’s previously announced patent allowance for its Antipathogenic Fibrous Materials composition patent, expanding the Company’s Intellectual Property (IP) to protect both the material itself and the processes that bring it to market. This dual coverage strengthens the Company’s competitive advantage, enhances licensing and partnership opportunities, and broadens potential applications across medical textiles, filtration media, and other infection-prone surfaces.
These two patent families create a comprehensive IP competitive barrier around SINTX’s surface-level pathogen-inactivation technology, covering applications in wound dressings, surgical drapes and gowns, filtration media, personal protective equipment (PPE), and high-touch clinical surfaces.
“We are excited to announce the allowance of our Method Patent for Antipathogenic Fibrous Materials, marking a significant milestone that strengthens and broadens the protection of our proprietary silicon nitride technology platform.” said Eric K. Olson, Chairman and CEO of SINTX Technologies. “This newly allowed patent complements the recently issued U.S. Patent No. 12,433,356, granted on October 7, 2025, which covers the composition of silicon nitride for antipathogenic fibrous materials. Together, these patents reinforce SINTX’s leadership in infection-resistant material innovation and expand the Company’s IP protection to cover both the composition of its fabrics and methods by which they are produced and applied. We believe this dual-layer IP foundation significantly enhances the licensing and commercialization potential of our platform.”
Lisa Marie, Del Re, Chief Commercial Officer, added, “With method claims, we can now defend and license the manufacturing and application pathways that unlock silicon nitride’s antipathogenic performance in textiles and surfaces. This is crucial as we engage with potential wound-care, filtration, and medical-textile partners.”
Scientific foundation and external validation
“Peer-reviewed work has repeatedly shown rapid inactivation of coronaviruses and broad antimicrobial activity associated with silicon nitride, including recent data reporting up to ~99.97% reduction of infectious SARS-CoV-2 within minutes under lab conditions,” said Dr. Ryan Bock, Chief Technology Officer. “Non-woven fabrics containing optimized Si₃N₄ powder have also provided significant viral reduction, demonstrating again that our silicon nitride platform is suitable for unlocking antipathogenic properties in a wide range of products.”
Note: Laboratory antiviral/antimicrobial results support the materials platform and are distinct from any cleared device indications.
Market context
Infection-prevention remains a large, multi-segment opportunity. SINTX previously characterized the accessible market for its platform as ~$30B across medical textiles, wound management, filtration/PPE, and healthcare infrastructure—an opportunity now underpinned by composition + method coverage.
At the care-delivery level, ~1 in 31 U.S. hospital patients has at least one healthcare-associated infection (HAI) on any given day, with substantial economic burden—reinforcing demand for passive, surface-level solutions that work continuously at the point of contact. (CDC data; cost ranges widely across HAI types.)
SINTX plans to pursue licensing and co-development partnerships with textile, wound care , and filtration/PPE partners. The dual-patent estate allows SINTX to license both materials embodiments and process methods, enabling flexible deal structures including upfronts, milestones, and royalties across multiple points in the supply-chain node.
For more information, visit www.sintx.com.
About SINTX Technologies, Inc.
Located in Salt Lake City, Utah, SINTX Technologies is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. SINTX is a global leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans since 2008. Through innovation and strategic partnerships, SINTX continues to expand its portfolio across multiple markets.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable securities laws. Forward-looking statements are based on current expectations, estimates, and projections and involve risks and uncertainties that could cause actual results to differ materially. Forward-looking statements often include words such as “anticipate,” “believe,” “expect,” “intend,” “may,” “plan,” “should,” “will,” and similar expressions. Examples in this release include, without limitation, statements regarding the anticipated commercial, licensing, and partnership potential of SINTX’s intellectual property (including newly allowed claims), the Company’s plans to pursue licensing, co-development, or other commercialization arrangements, expectations about market opportunities and expansion into new markets, and the Company’s competitive positioning. These statements are subject to risks and uncertainties, including SINTX’s ability to execute its business strategy; protect and enforce its intellectual property; successfully enter into and perform under licensing and partner relationships; obtain necessary regulatory approvals; achieve market acceptance of new technologies; general economic and industry conditions; and other risks described in SINTX’s filings with the U.S. Securities and Exchange Commission, including the “Risk Factors” sections of its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this release. Except as required by law, SINTX undertakes no obligation to update or revise any forward-looking statements.
Contact:
Jack Perkins or Maria Hocut
KCSA Strategic Communications
Sintx@kcsa.com
SINTX Technologies, Inc.
801.839.3502
IR@sintx.com
SOURCE: SiNtx Technologies, Inc.
DEEL SECURES US$300 MLN INVESTMENT, VALUED AT US$17.3 BLN
%20B.jpg) |
| Deel reached $1bn revenue faster than many high-growth tech industry peers due to its impressive organic growth engine and ability to scale at speed. Source: S-1 Filings, GS Research, FactSet. |
KUALA LUMPUR, Oct 17 (Bernama) -- Deel, the global human resources (HR) and payroll platform, has secured a US$300 million strategic investment led by Ribbit Capital, with continued backing from existing investors Andreessen Horowitz and Coatue Management, with participation from General Catalyst, Green Bay Ventures and others. (US$1=RM4.21)
According to the company in a statement, the raise pushes Deel’s valuation to US$17.3 billion.
The investment follows a record year of performance for the company, which achieved its three consecutive years of profitability, and recorded its first US$100 million revenue month in September. Earlier this year, Deel also surpassed US$1 billion in annual recurring revenue.
Currently, the company serves over 37,000 businesses and 1.5 million workers across more than 150 countries, processing US$22 billion in payroll annually.
Deel co-founder and chief executive officer, Alex Bouaziz said the new capital will support the company’s mission to redefine global payroll infrastructure and strengthen its position as a single platform for companies to build, manage and pay their teams worldwide.
“This round is about doubling down on the global payroll infrastructure we have built from the ground up. We are reimagining how payroll should work for the next century—fluid, real-time and truly borderless,” he said.
Proceeds from the investment will be used to accelerate strategic acquisitions, expand product capabilities and enhance global reach. Deel also plans to invest in artificial intelligence innovation and the continued development of its owned systems, aiming to deliver native payroll in over 100 countries by 2029.
The company reported strong growth across all product segments, including a 1,500 per cent increase in United States (US) payroll services, 600 per cent growth in HR products and 450 per cent expansion in global payroll.
Other notable achievements include a 220 per cent increase in its immigration product, 410 per cent growth in information technology (IT) services, and a 1,200 per cent surge in customers using four or more products.
-- BERNAMA
Subscribe to:
Comments (Atom)